Beverly Hills Suboxone Doctors


Join Here To Have Your Medical Practice Featured in this space
and in the Google Map located below

Following payment completion, please send us the listing information you would like displayed here.

methadone8c



Beverly Hills provides numerous choices in local physicians who are approved to prescribe buprenorphine for opioid addiction and withdrawal. Buprenorphine is the component in the popular medication, suboxone, which alleviates opiate withdrawal symptoms like chills, nausea, vomiting, and diarrhea. Doctors approved for suboxone treatment have taken training in the proper administration of suboxone. Suboxone has acquired a positive reputation in the medical community due to its comparatively good safety profile and its rapid effectiveness in eliminating opioid withdrawal sickness. If you are a local physician who treats Beverly Hills residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



Beverly Hills Buprenorphine Suboxone Doctors
Criselda Abad-Santos, M.D. 433 North Camden Drive
Suite 400
Beverly Hills, CA 90210
(310) 887-1447
Barry Friedman, M.D. 9171 Wilshire Boulevard
Suite 310
Beverly Hills, CA 90210
(310) 274-4372
Steven J. Jacobs, M.D. 436 North Bedford Drive
Suite 214
Beverly Hills, CA 90210
(310) 271-2328
Samuel A. Park, M.D. 9301 Wilshire Boulevard
Suite 601
Beverly Hills, CA 90210
(310) 777-0490
Robert Louis Saltzman, M.D. 9400 Brighton Way
Suite 404
Beverly Hills, CA 90210
(310) 550-8028
Parviz D. Fahimian, M.D. 435 North Bedford Drive
Suite 313
Beverly Hills, CA 90210
(310) 888-7733
Jeffrey Gandin, M.D. 450 North Bedford Drive
Suite 307
Beverly Hills, CA 90210
(310) 497-8900
Edward Riceberg, M.D. 9400 Brighton Way
Suite 404
Beverly Hills, CA 90210
(310) 550-8028
Sophie Francoise Duriez, M.D. 9400 Brighton Way
Suite 407
Beverly Hills, CA 90210
(310) 271-8407
Litos O. Mallare, M.D. 9171 Wilshire Boulevard
Suite 310
Beverly Hills, CA 90210
(310) 274-4327
Ryan A. Stanton, M.D. 9090 Barton Way
Beverly Hills, CA 90211
(310) 278-0077
Oliver Abbas Ahmadpour, M.D. 239 South La Cienega Boulevard
Suite 210
Beverly Hills, CA 90211
(310) 691-5005
James Daniel, M.D. 150 North Robertson Boulevard
Suite 350 N
Beverly Hills, CA 90211
(310) 360-7670
Lawrence Ross Miller, M.D. 8641 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
(310) 657-7246
Dana Gregory Eisenman, M.D. 150 North Robertson Boulevard
Suite 350
Beverly Hills, CA 90211
(310) 360-7671
Jonathan Reitman, M.D. 8920 Wilshire Boulevard
Suite 310
Beverly Hills, CA 90211
(310) 360-7690
Mark Robert Honzel, M.D. 8920 Wilshire Boulevard
Suite 310
Beverly Hills, CA 90211
(310) 360-7690
Gary Ross Cohan, M.D. 150 North Robertson Boulevard
Unit 115
Beverly Hills, CA 90211
(310) 657-6900
Rodney Daniel Collins, M.D. New Division Medical Group, Inc.
8920 Wilshire Boulevard, Unit 310
Beverly Hills, CA 90211
(310) 360-7690
Adam David Karns, M.D. 8920 Wilshire Boulevard
Suite 321
Beverly Hills, CA 90211
(310) 652-8084
Arastou Aminzadeh, M.D. 239 South La Cienega Boulevard
Suite 210
Beverly Hills, CA 90211
(310) 691-5005
Behnoush Zarrini, M.D. 8670 Wilshire Boulevard
Suite 206
Beverly Hills, CA 90211
(310) 409-3537
Thom E. Lobe, M.D. 50 North La Cienega
Suite 215
Beverly Hills, CA 90211
(310) 289-2800
Bahman Omrani, D.O. 206 South Robertson Boulevard
Beverly Hills, CA 90211
(310) 657-8759
Michael D. Stone, D.O. 8920 Wilshire Boulevard
Suite 310
Beverly Hills, CA 90211
(310) 360-7690
George John Graf, M.D. 120 South Spalding Drive
Suite 301
Beverly Hills, CA 90212
(310) 657-6226
Arif (Reef) Karim, D.O. 9777 Wilshire Boulevard
Suite 704
Beverly Hills, CA 90212
(310) 271-8700
Phillip J. Bowman, M.D. 9777 Wilshire Boulevard
Suite 707
Beverly Hills, CA 90212
(310) 276-4003
Preetpal Singh Sandhu, M.D. 9478 Olympic Blvd.
Suite 308
Beverly Hills, CA 90212
(310) 622-4153
Kamyar Cohanshohet, M.D. 9730 Wilshire Boulevard
Suite 202
Beverly Hills, CA 90212
(310) 278-1222
Gail Carolyn Brady, M.D. 300 South Beverly Drive
Suite 205
Beverly Hills, CA 90212
(310) 601-4839
Serena Puga, M.D. 420 South Beverly Drive
Suite 207
Beverly Hills, CA 90212
(310) 228-7880
David Alan Kipper, M.D. 153 South Lasky Drive
Beverly Hills, CA 90212
(310) 275-5206
Stephen M. Scappa, M.D. 9730 Wilshire Boulevard
Suite 213
Beverly Hills, CA 90212
(310) 273-2598
Guven Uzun, M.D. 415 North Crescent Drive
Suite 220
Beverly Hills, CA 92102
(310) 888-2877


Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Posted in Acadia Healthcare, Addiction Treatment, Brightview, Methadone, Methadone Clinics, Opioid Treatment, Suboxone | Tagged | Comments Off on Expanding Access to Methadone